SPI.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 17:36):

Stats
Dagens volum	227 455
Gjennomsnittsvolum	559 147
Markedsverdi	1.00B
EPS	£0 ( 2024-02-28 )
Last Dividend	£0.500 ( 2023-05-25 )
Next Dividend	£0 ( N/A )
P/E	35.43
ATR14	£0.161 (0.06%)

Volum Korrelasjon

Lang: -0.03 (neutral)

Kort: -0.12 (neutral)

Signal:(52.726) Neutral

Spire Healthcare Group Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Spire Healthcare Group Korrelasjon - Valuta/Råvare

-0.68
( moderate negative )

0.17
( neutral )

-0.18
( neutral )

-0.71
( moderate negative )

-0.11
( neutral )

-0.75
( moderate negative )

Spire Healthcare Group Økonomi

Annual	2023
Omsetning:	£1.36B
Bruttogevinst:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2023
Omsetning:	£1.36B
Bruttogevinst:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2022
Omsetning:	£1.20B
Bruttogevinst:	£440.50M (36.75 %)
EPS:	£0.0214

FY	2021
Omsetning:	£1.11B
Bruttogevinst:	£491.20M (44.40 %)
EPS:	£-0.0240

Financial Reports:

No articles found.

Spire Healthcare Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0.500 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Spire Healthcare Group Dividend Information - Dividend Junior

Dividend Sustainability Score: 8.47 - good (84.72%) | Divividend Growth Potential Score: 4.15 - Stable (17.00%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£1.800	2015-06-04
Last Dividend	£0.500	2023-05-25
Next Dividend	£0	N/A
Payout Date	2023-06-23
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	£21.20	--
Avg. Dividend % Per Year	0.18%	--
Score	2.58	--
Div. Sustainability Score	8.47
Div.Growth Potential Score	4.15
Div. Directional Score	6.31	--

Next Divdend (Est)
(2024-05-09)

£0.0693 Estimate 3.33 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.58

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£3.80	1.64%
2019	£3.80	3.44%
2020	£2.50	1.76%
2021	£0	0.00%
2022	£0	0.00%
2023	£0.500	0.22%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SCF.L	Dividend Knight	2023-07-06	Quarterly	30	2.18%
HUR.L	Dividend King	2023-06-08	Insufficient data to determine frequency	2	21.63%
BERI.L	Dividend Knight	2023-09-28	Quarterly	19	2.36%
WINK.L	Dividend King	2023-07-20	Quarterly	15	3.81%
NAIT.L	Dividend Knight	2023-07-20	Quarterly	53	2.33%
EDIN.L	Dividend King	2023-06-08	Quarterly	53	2.46%
SNWS.L	Dividend Knight	2023-06-08	Annually	32	4.00%
ITRK.L	Dividend Knight	2023-09-14	Semi-Annually	22	1.44%
BRSC.L	Dividend Knight	2023-05-18	Semi-Annually	47	1.21%
PFD.L	Dividend Knight	2023-06-29	Sporadic	20	0.70%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0201	1.500	9.60	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0119	1.200	9.60	10.00	[0 - 0.3]
returnOnEquityTTM	0.0372	1.500	-0.698	-1.047	[0.1 - 1]
payoutRatioTTM	0.0733	-1.000	9.27	-9.27	[0 - 1]
currentRatioTTM	0.691	0.800	-1.544	-1.236	[1 - 3]
quickRatioTTM	0.483	0.800	-1.867	-1.493	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.243	-0.365	[0.2 - 2]
debtRatioTTM	0.203	-1.500	6.62	-9.93	[0 - 0.6]
interestCoverageTTM	1.360	1.000	-0.607	-0.607	[3 - 30]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.286	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.627	-1.500	7.49	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.383	1.000	6.95	6.95	[0.2 - 0.8]
operatingProfitMarginTTM	0.0931	1.000	-0.138	-0.138	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.431	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	0.594	0.800	9.37	7.50	[0.5 - 2]
Total Score				8.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.29	1.000	6.44	0	[1 - 100]
returnOnEquityTTM	0.0372	2.50	-0.449	-1.047	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.286	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0.204	1.500	4.91	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
payoutRatioTTM	0.0733	1.500	9.27	-9.27	[0 - 1]
pegRatioTTM	-38.04	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.82	0	[0.1 - 0.5]
Total Score				4.15

Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.